Shopping security
foxo4-dri senolytic or senomorphic The disordered p53 transactivation domain is the target of FOXO4 and the compound Peptid NL-GHK-Cu™ (TETRAPEPTID +
Peptid NL-GHK-Cu™ (TETRAPEPTID + CU) | Synthagen – Synthagen EU
GHK alone has limited biological activity
NON DEAL
Dosage:2mg
If neurological symptoms are present (such as paraesthesia, ataxia, cognitive changes, or visual disturbances), more intensive treatment is required
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
US$40
Get nowSign up to your membership to get coupons up to
15%
Get nowOpportunity to enjoy order discount up to 15% off
Do not assume every advertised method works for every product option. Ask about unresolved status before attempting another payment.
Check whether access to a purchased benefit depends on the account. Review whether the requested action is temporary deactivation or permanent closure.
Look for the existing order in the purchase channel's order history. Check whether a second record is an amendment rather than a separate purchase.